Article Details
Retrieved on: 2024-08-08 19:06:24
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article announces Teresa Lambe joining GeoVax's Scientific Advisory Board, leveraging her vast vaccine development expertise—especially pivotal for strategic growth in COVID-19 and other infectious disease vaccines. Her role aligns with GeoVax's business strategy of pioneering advanced immunotherapies.
Article found on: quantisnow.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here